Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Vasculitis
How would you approach a patient with high titer PR3 antibodies checked as part of a GI workup for abdominal pain and diarrhea in a patient without any pulmonary/renal or IBD symptoms?
Related Questions
What imaging do you prefer for screening of large vessel involvement in GCA and do you routinely get that in all newly diagnosed cases?
How long do you continue immunosuppression in patients with Behcet's who have a history of mucocutaneous and ocular disease, but are now in remission?
Do you offer biosimilar tocilizumab as an alternative to subcutaneous or infusion brand-name tocilizumab when treating GCA?
What would be the preferred treatment option for PMR if patient develops gastric perforation soon after initiation of steroids?
How would you approach the work up of a patient with nasal septal perforation, a negative infectious workup, and negative ANCA titers?
How do you approach the work up of pulmonary artery aneurysm in the absence of other clinical features of Behcet’s?
What is your approach to immunosuppression in an adult patient with biopsy-proven IgA vasculitis who has new and severe acute renal failure requiring dialysis?
Do you recommend monitoring IgG level in patients with AAV receiving rituximab?
Do you typically screen every patient with headaches after the age of 60 with ESR?
How would you approach a patient with GCA who develops necrotizing fasciitis and then flares because they are off of tocilizumab?